Simultaneous determination of albendazole and praziquantel in rat plasma by HPLC-UV
暂无分享,去创建一个
K. Kant | S. Dey | M. Ghosh | Shreya Shah | P. Behera | Suddhasattya Dey
[1] H. Jung-Cook,et al. Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies. , 2006, Journal of Antimicrobial Chemotherapy.
[2] N. Medlicott,et al. Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma. , 2005, Journal of pharmaceutical and biomedical analysis.
[3] N. Lopes,et al. Biomimetic oxidation of praziquantel catalysed by metalloporphyrins , 2005 .
[4] K. Kieć‐Kononowicz,et al. The research on biotransformation of praziquantel. , 2004, Acta Poloniae Pharmaceutica - Drug Research.
[5] Xiaoyan Chen,et al. Simultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric method. , 2004, Journal of pharmaceutical and biomedical analysis.
[6] K. Pengsaa,et al. Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis , 2004, Annals of tropical medicine and parasitology.
[7] A. Dash,et al. Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] O. Takayanagui. Therapy for neurocysticercosis , 2004, Expert review of neurotherapeutics.
[9] A. Goudah. Aspects of the Pharmacokinetics of Albendazole Sulphoxide in Sheep , 2003, Veterinary Research Communications.
[10] A. Flisser,et al. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. , 2003, Acta tropica.
[11] P. S. Bonato,et al. Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] M. Rouini,et al. A high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serum. , 2002, Journal of pharmaceutical and biomedical analysis.
[13] L. Fleckenstein,et al. HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. , 2002, Journal of pharmaceutical and biomedical analysis.
[14] P. S. Bonato,et al. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis. , 2002, British journal of clinical pharmacology.
[15] M. Wongnawa,et al. LC determination of praziquantel in human plasma. , 2002, Journal of pharmaceutical and biomedical analysis.
[16] J. Bligh,et al. A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London. , 2002, Annals of the Royal College of Surgeons of England.
[17] G. Blaschke,et al. Investigation of praziquantel metabolism in isolated rat hepatocytes. , 2001, Journal of pharmaceutical and biomedical analysis.
[18] E. Formentini,et al. Pharmacokinetics of ricobendazole in calves. , 2001, Journal of veterinary pharmacology and therapeutics.
[19] G. Blaschke,et al. Capillary electrophoresis-mass spectrometry, liquid chromatography-mass spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[20] W. Thormann,et al. Therapeutic drug monitoring of albendazole: Determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis , 2000, Electrophoresis.
[21] F. Bolás-Fernández,et al. Quantitative determination of albendazole and its main metabolites in plasma. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[22] J. Torrado,et al. A Selective and Simple RP-HPLC Assay To Quantify Albendazole Metabolites in Plasma , 1998 .
[23] M. A. al Karawi,et al. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. , 1998, Hepato-gastroenterology.
[24] Cobo,et al. Albendazole plus praziquantel versus albendazole alone as a pre‐operative treatment in intra‐abdominal hydatidosis caused by Echinococcus granulosus , 1998, Tropical medicine & international health : TM & IH.
[25] G. Blaschke,et al. Investigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[26] P. S. Bonato,et al. Determination of albendazole metabolites in plasma by HPLC. , 1994, Journal of analytical toxicology.
[27] M. A. al Karawi,et al. Combination of praziquantel and albendazole in the treatment of hydatid disease. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[28] F. Westhoff,et al. High-performance liquid chromatographic determination of the stereoselective biotransformation of the chiral drug praziquantel. , 1992, Journal of chromatography.
[29] V. Lanchote,et al. Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis. , 2004, Chirality.
[30] G. Schmahl,et al. Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite onSchistosoma mansoni in vitro , 2004, Parasitology Research.
[31] D. Guo,et al. [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis]. , 2003, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.